Medicure Inc. (TSXV: MPH)
Canada
· Delayed Price · Currency is CAD 0.880
-0.010 (-1.12%)
Dec 27, 2024, 3:01 PM EST
Medicure Revenue
Medicure had revenue of 5.15M CAD in the quarter ending September 30, 2024, with 3.02% growth. This brings the company's revenue in the last twelve months to 21.08M, down -8.09% year-over-year. In the year 2023, Medicure had annual revenue of 21.69M, down -5.94%.
Revenue (ttm)
21.08M
Revenue Growth
-8.09%
P/S Ratio
0.44
Revenue / Employee
554.82K
Employees
38
Market Cap
9.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 21.69M | -1.37M | -5.94% |
| Dec 31, 2022 | 23.07M | 1.32M | 6.08% |
| Dec 31, 2021 | 21.74M | 10.13M | 87.29% |
| Dec 31, 2020 | 11.61M | -8.56M | -42.45% |
| Dec 31, 2019 | 20.17M | -8.94M | -30.70% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch + Lomb Corporation | 6.33B |
| Bausch Health Companies Inc. | 12.80B |
| Tilray Brands, Inc. | 1.10B |
| WELL Health Technologies Corp. | 957.69M |
| Curaleaf Holdings, Inc. | 1.83B |
| dentalcorp Holdings Ltd. | 1.51B |
| Sienna Senior Living Inc. | 867.55M |
| Cronos Group Inc. | 150.26M |
Medicure News
- 4 weeks ago - Medicure GAAP EPS of C$0.07, revenue of C$5.2M - Seeking Alpha
- 4 weeks ago - Medicure Reports Financial Results For Quarter Ended September 30, 2024 - Accesswire
- 5 weeks ago - Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member - Accesswire
- 2 months ago - Medicure Announces Positive Settlement of Product Development and Supply Contracts - Accesswire
- 4 months ago - Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property - Accesswire
- 4 months ago - Medicure Reports Financial Results for Quarter Ended June 30, 2024 - Accesswire
- 6 months ago - Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property - Accesswire
- 8 months ago - Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency - Accesswire